This is all relatively new. One of the government funds set up by the former government, continued by the present government, is the Canada first research excellence fund. Some of the funding came from it. The chief aim, obviously, is research on neurodegenerative diseases.
In this field there's really been almost no advance made in 30 years. We've been doing the same thing over and over again, so it was felt we needed a kick to the research community. That money was matched by provincial money and, as I said, it's attracted interest from all kinds of firms. I'm not sure I'm allowed to tell you which ones yet, as I don't know if they're public, but large pharma firms, biotech firms, and IT firms are interested. They're all coming.
The research is just starting. Interestingly enough, we're developing very detailed metrics of innovation and the success of this. The theory is that we're going to get a lot more firms involved. We're already seeing that, but this is all ad hoc. As an empiricist, I'm not confident yet, but we're seeing good signs that these firms are coming together and calling up the MNI to do research. We'll know in about five years whether we've succeeded. It's way too early.
We're seeing a lot of enthusiasm. We've had coverage in The Guardian. The European Commission and the OECD are interested. I'm being funded by the Gates Foundation and Wellcome Trust. There's a ton of interest, but I can't come to you with solid figures on how many jobs this has generated. We don't know that yet.